Invenomic Capital Management LP trimmed its position in FONAR Co. (NASDAQ:FONR – Free Report) by 11.5% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 116,402 shares of the medical equipment provider’s stock after selling 15,128 shares during the […]
Stock analysts at StockNews.com began coverage on shares of FONAR (NASDAQ:FONR – Get Free Report) in a report released on Thursday. The brokerage set a “strong-buy” rating on the medical equipment provider’s stock. FONAR Stock Performance NASDAQ FONR opened at $14.61 on Thursday. The stock has a market capitalization of $94.23 million, a P/E ratio […]
FONAR Co. (NASDAQ:FONR – Get Free Report) saw a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 16,700 shares, a growth of 16.8% from the August 31st total of 14,300 shares. Based on an average trading volume of 7,900 shares, the short-interest ratio is […]
StockNews.com started coverage on shares of FONAR (NASDAQ:FONR – Free Report) in a research note issued to investors on Thursday. The firm issued a strong-buy rating on the medical equipment provider’s stock. Separately, TheStreet upgraded shares of FONAR from a c+ rating to a b- rating in a research report on Thursday, June 1st. View […]
FONAR Co. (NASDAQ:FONR – Get Free Report) was the target of a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 11,700 shares, a decline of 14.0% from the July 15th total of 13,600 shares. Based on an average trading volume of 8,800 shares, the […]